Canopy Growth Corp Expands into U.S. Cannabis Market

1.4 min readPublished On: April 23rd, 2024By

LOS ANGELES- Canopy Growth Corp, a Canada-based cannabis company, has secured approval from its shareholders to venture into the American cannabis market via its newly established subsidiary, Canopy USA. This strategic move involves a novel share structure that supports the company’s compliance with U.S. regulations while facilitating market entry.

Under the new system, Canopy Growth will issue an unlimited number of new class non-voting and non-participating exchangeable shares, convertible into ordinary Canopy shares. This restructuring allows the firm to navigate the regulatory landscape effectively, paving the way for its entry into the lucrative U.S. market.

Canopy USA will take over the existing American cannabis assets from its Canadian parent, including significant industry names such as Acreage, Jetty, and Wana. This acquisition is part of a broader strategy to deconsolidate the financial results of Canopy USA and maintain a non-controlling interest in the subsidiary, thereby providing Canopy Growth with greater flexibility in managing its international operations while focusing on core business areas.

CEO David Klein expressed optimism regarding the future rescheduling of cannabis in the U.S., which he believes could significantly enhance cash flow for the company’s U.S. assets. The anticipation of regulatory changes in cannabis scheduling suggests a positive outlook for the industry, potentially benefiting operations and cash flow significantly.

This expansion into the U.S. market not only aims to generate revenue and cost synergies but also positions Canopy Growth as a pioneer in the sector, potentially the first U.S.-listed cannabis firm to offer a unique market exposure. This move is expected to strengthen the company’s competitive edge in the rapidly evolving cannabis industry.

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!